AllSquare Wealth Management’s Filana Therapeutics FLNA Stock Holding History

AllSquare Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.45K	Hold	1,186	–	–	﹤0.01%	446
2025 Q2	$2.15K	Hold	1,186	–	–	﹤0.01%	465
2025 Q1	$1.78K	Hold	1,186	–	–	﹤0.01%	473
2024 Q4	$2.8K	Buy	1,186 +1,000	+538%	+$17.6K	﹤0.01%	454
2024 Q3	$5.47K	Hold	186	–	–	﹤0.01%	427
2024 Q2	$2.3K	Hold	186	–	–	﹤0.01%	462
2024 Q1	$3.77K	Sell	186 -400	-68%	-$9.22K	﹤0.01%	439
2023 Q4	$13.2K	Buy	586 +88	+18%	+$1.86K	0.01%	345
2023 Q3	$8.29K	Hold	498	–	–	0.01%	386
2023 Q2	$11.4K	Hold	498	–	–	0.01%	365
2023 Q1	$12K	Hold	498	–	–	0.01%	358
2022 Q4	$14.7K	Hold	498	–	–	0.01%	318
2022 Q3	$21K	Hold	498	–	–	0.02%	273
2022 Q2	$14K	Hold	498	–	–	0.01%	328
2022 Q1	$18K	Hold	498	–	–	0.01%	327
2021 Q4	$22K	Hold	498	–	–	0.01%	313
2021 Q3	$31K	Buy	498 +186	+60%	+$15.5K	0.02%	271
2021 Q2	$27K	Hold	312	–	–	0.02%	299
2021 Q1	$14K	Buy	312 +42	+16%	+$1.65K	0.01%	356
2020 Q4	$2K	Hold	270	–	–	﹤0.01%	434
2020 Q3	$3K	Hold	270	–	–	﹤0.01%	413
2020 Q2	$1K	Hold	270	–	–	﹤0.01%	456
2020 Q1	$1K	Buy	+270	New	+$1.79K	﹤0.01%	437

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

AllSquare Wealth Management's FLNA Position: Q3 2025 in Review

AllSquare Wealth Management held its Filana Therapeutics (FLNA) position steady in Q3 2025 at 1,186 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

AllSquare Wealth Management first reported a position in FLNA in Q1 2020 and has held it in 23 quarters since. The position peaked at $31K in Q3 2021. 103 funds tracked by Wall St. Rank hold FLNA as of Q3 2025.

AllSquare Wealth Management held 1,186 shares of Filana Therapeutics worth $3.45K as of Q3 2025.
AllSquare Wealth Management left its Filana Therapeutics share count unchanged in Q3 2025.
Filana Therapeutics made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #446 holding.
AllSquare Wealth Management first reported a position in Filana Therapeutics in Q1 2020 and has held it in 23 quarters since.
AllSquare Wealth Management's Filana Therapeutics position peaked at $31K in Q3 2021.
103 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.